TY  - GEN
AU  - Miller,Ashley M
AU  - Ozenci,Volkan
AU  - Kiessling,Rolf
AU  - Pisa,Pavel
TI  - Immune monitoring in a phase 1 trial of a PSA DNA vaccine in patients with hormone-refractory prostate cancer
SN  - 1524-9557
PY  - 2005///1017
KW  - Antigen Presentation
KW  - immunology
KW  - Antigens, CD
KW  - analysis
KW  - Antineoplastic Agents, Hormonal
KW  - pharmacology
KW  - CD8-Positive T-Lymphocytes
KW  - Coculture Techniques
KW  - Dendritic Cells
KW  - Drug Resistance, Neoplasm
KW  - Humans
KW  - Immunity, Cellular
KW  - Immunophenotyping
KW  - Interferon-gamma
KW  - metabolism
KW  - Interleukin-10
KW  - Interleukins
KW  - Lymphocyte Activation
KW  - Male
KW  - Monitoring, Immunologic
KW  - Peptide Fragments
KW  - Prostate-Specific Antigen
KW  - genetics
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - T-Lymphocytes
KW  - Vaccines, DNA
KW  - administration & dosage
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1097/01.cji.0000165353.19171.41
ER  -